Marc Tessier-Lavigne, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 14,584 shares at $699.82 ($10.2M) on 2022-09-29, disclosed to the SEC on 2022-10-03.
Open-market sale of $10.2M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $686.89 | 16 | $11K | 0.1% |
| 2 | $687.90 | 321 | $221K | 2.2% |
| 3 | $687.90 | 321 | $221K | 2.2% |
| 4 | $688.71 | 637 | $439K | 4.3% |
| 5 | $688.71 | 637 | $439K | 4.3% |
| 6 | $689.56 | 1,009 |
| $696K |
| 6.8% |
| 7 | $689.56 | 1,009 | $696K | 6.8% |
| 8 | $690.65 | 692 | $478K | 4.7% |
| 9 | $690.65 | 692 | $478K | 4.7% |
| 10 | $691.59 | 554 | $383K | 3.8% |
| 11 | $691.59 | 554 | $383K | 3.8% |
| 12 | $696.13 | 85 | $59K | 0.6% |
| 13 | $696.13 | 85 | $59K | 0.6% |
| 14 | $697.29 | 160 | $112K | 1.1% |
| 15 | $697.29 | 160 | $112K | 1.1% |
| 16 | $698.44 | 208 | $145K | 1.4% |
| 17 | $698.44 | 208 | $145K | 1.4% |
| 18 | $699.82 | 80 | $56K | 0.5% |
| 19 | $699.82 | 80 | $56K | 0.5% |
| 20 | $702.36 | 16 | $11K | 0.1% |
| 21 | $704.83 | 20 | $14K | 0.1% |
| 22 | $698.00 | 3,428 | $2.4M | 23.5% |
| 23 | $718.00 | 3,612 | $2.6M | 25.4% |
| Total | $699.34 avg | 14,584 | $10.2M | 100% |
| Filing → |
| DNLI | SELL | 2022-09-30 | $1.2M | — | Filing → |
| DNLI | SELL | 2022-08-25 | $632K | — | Filing → |
| DNLI | SELL | 2022-07-27 | $712K | — | Filing → |